Evotec SE (EVO) Non-Current Debt (2009 - 2026)
Evotec SE's (EVO) quarterly Non-Current Debt came in at $481.6 million in Q2 2026, up 19.77% year-over-year from $402.1 million in Q2 2025, and up 37.65% quarter-over-quarter from $349.9 million in Q1 2026.
Analysis
Evotec SE (EVO) Non-Current Debt (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Debt across 9 years of filings, most recently posting $481.6 million for Q2 2026.
- In Q2 2026, Non-Current Debt rose 19.77% year-over-year to $481.6 million; the TTM figure through Jun 2026 stood at $481.6 million (up 19.77% YoY), while the FY2025 annual figure was $388.7 million, down 8.57% from the prior year.
- Non-Current Debt came in at $481.6 million for Q2 2026 at Evotec SE, up from $349.9 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $513.3 million in Q4 2023 to a low of -$349.7 million in Q2 2022.
- Average Non-Current Debt over 5 years is $370.0 million, with a median of $418.1 million recorded in 2023.
- Year-over-year, Non-Current Debt soared 219.11% in 2023 and declined 20.39% in 2026.
- Over 5 years, Non-Current Debt stood at $500.2 million in 2022, then advanced by 2.62% to $513.3 million in 2023, then dropped by 18.25% to $419.7 million in 2024, then decreased by 4.59% to $400.4 million in 2025, then increased by 20.27% to $481.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $481.6 million in Q2 2026, $349.9 million in Q1 2026, and $400.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 13.71 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 2.62 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 2.11 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 1.04 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 481.59 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 481.59 Mn |
| Mar 31, 2026 | 349.87 Mn |
| Dec 31, 2025 | 400.44 Mn |
| Sep 30, 2025 | 453.29 Mn |
| Jun 30, 2025 | 402.09 Mn |
| Mar 31, 2025 | 439.47 Mn |
| Dec 31, 2024 | 419.68 Mn |
| Sep 30, 2024 | 457.42 Mn |
| Dec 31, 2023 | 513.34 Mn |
| Jun 30, 2023 | 416.52 Mn |
| Dec 31, 2022 | 500.22 Mn |
| Sep 30, 2022 | 329.48 Mn |
| Jun 30, 2022 | -349.70 Mn |
| Mar 31, 2022 | 366.01 Mn |
| Dec 31, 2021 | 373.33 Mn |
| Sep 30, 2021 | 374.92 Mn |
| Dec 31, 2020 | 394.67 Mn |
| Sep 30, 2010 | 3.87 Mn |
| Jun 30, 2010 | 3.82 Mn |
| Mar 31, 2010 | 5,007.11 |